TrialJournal of clinical immunology2016

Efficacy, Safety, and Pharmacokinetics of a Novel Human Immune Globulin Subcutaneous, 20 % in Patients with Primary Immunodeficiency Diseases in North America.

Daniel Suez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.